Massachusetts negotiates HCV discounts

MassHealth, Massachusetts' state Medicaid program, said drug makers Gilead Sciences Inc. (NASDAQ:GILD) and Bristol-Myers Squibb Co. (NYSE:BMY) agreed to provide rebates that would give all MassHealth members access to HCV drugs

Read the full 314 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE